proxyvotesnow.com

Home › Companies › NEOGENOMICS INC. › 2024-2025

NEOGENOMICS INC. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and NEOGENOMICS INC.’s Form 8-K, filed 2025-05-27 (Item 5.07 on EDGAR). Page generated 04 October 2026.

  • 15Reported items
  • 306Asset managers
  • 4,283Fund votes
  • 2025-05-22Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore NEOGENOMICS INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by NEOGENOMICS INC.

These tallies are NEOGENOMICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-05-27 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

NEOGENOMICS INC. — official shareholder meeting results, meeting held 2025-05-22
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Lynn A. Tetrault 100,642,8896,808,24648,405 --5,711,547 Majority: yes
Elect Director: Elizabeth A. Floegel 106,521,107909,20769,226 --5,711,547 Majority: yes
Elect Director: Dr. Neil Gunn 100,989,2606,479,24331,037 --5,711,547 Majority: yes
Elect Director: Dr. Alison L. Hannah 106,228,8941,212,69457,952 --5,711,547 Majority: yes
Elect Director: Stephen M. Kanovsky 106,382,2281,084,96932,343 --5,711,547 Majority: yes
Elect Director: Michael A. Kelly 100,543,9176,924,00131,622 --5,711,547 Majority: yes
Elect Director: David B. Perez 100,863,4096,606,02530,106 --5,711,547 Majority: yes
Elect Director: Felicia Williams 106,671,209779,50448,827 --5,711,547 Majority: yes
Elect Director: Anthony P. Zook 106,854,626577,38267,532 --5,711,547 Majority: yes
Proposal 2: The approval, on an advisory basis, of the compensation paid to the Company's Named Executive Officers, as identified in the proxy statement for the Annual Meeting. The advisory approval received an affirmative vote of a majority of the votes cast 87,823,18919,573,234103,117 --5,711,547 Majority: yes
Proposal 4: The approval of the Amendment, as identified in the proxy statement for the Annual Meeting. The stockholders approved the proposal by the following vote: 101,800,1245,467,338232,078 --5,711,547 Majority: yes
Proposal 5: The ratification of the appointment of Deloitte & Touche LLP as the independent registered public accountant. The stockholders approved the proposal by the following vote: 112,929,861157,649123,577 ---- Majority: yes

Source: NEOGENOMICS INC., Form 8-K, filed with the SEC on 2025-05-27 — read the filing on EDGAR.

How asset managers voted at the NEOGENOMICS INC. 2024-2025 meeting

Each item below shows how the 306 asset managers that disclosed a NEOGENOMICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of NEOGENOMICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Approval, on a non-binding advisory basis, of the Compensation Paid to the Company's Named Executive Officers.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 10 wordings of this item as funds reported it.

82% Majority: yes · of votes cast

FOR 82%AGAINST 18%
FOR: 87,823,189AGAINST: 19,573,234

NEOGENOMICS INC.’s own tally for this item (“Proposal 2: The approval, on an advisory basis, of the compensation paid to the Company's Named Executive Officers, as identified in the proxy statement for the Annual Meeting. The advisory approval received an affirmati”): 87,823,189 for, 19,573,234 against, per its Form 8-K filed 2025-05-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 128,356,327 outstanding shares: 68% for, 15% against (84% of the company cast a for/against vote).

The 302 asset managers below cast 82% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.

FOR 82%AGAINST 18%
FOR: 82.4%AGAINST: 17.5%ABSTAIN: 0.0%NOT VOTED: 0.1%
Largest asset managers voting on “Approval, on a non-binding advisory basis, of the Compensation Paid to the Company's Named Executive Officers.” at NEOGENOMICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock16,507,89120,442 00For
Vanguard14,392,4914,465 00For
State Street6,456,673156,788 00For
T. Rowe Price5,923,1220 00For
First Light Asset Management, LLC5,427,1800 00For
American Century5,376,5390 00For
Janus Henderson5,125,5210 00For
MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST4,237,7720 00For
SCHRODER INVESTMENT MANAGEMENT GROUP04,184,156 00Against
JANUS INVESTMENT FUND4,142,0540 00For
Delaware/Macquarie3,827,2920 00For
Greenhouse Funds LLLP3,620,2250 00For
Dimensional03,546,557 00Against
BROWN ADVISORY INC3,192,02913,349 00For
Loomis Sayles117,9132,622,255 00Against
Charles Schwab2,159,3550 00For
GEODE CAPITAL MANAGEMENT, LLC1,717,7790 00For
Fidelity1,585,6720 00For
FRANKLIN ADVISERS INC81,4001,312,713 00Against
JENNISON ASSOCIATES LLC01,370,030 00Against
FRANKLIN STRATEGIC SERIES01,247,115 00Against
SEGALL BRYANT & HAMILL, LLC1,230,7050 00For
Northern Trust1,055,9610 00For
Goldman Sachs1,030,3700 00For
GLENMEDE FUND INC1,002,1670 00For

Showing the 25 largest of 302 asset managers. See all 302 in the interactive database.

2. Recommend, on a non-binding advisory basis, the Frequency of Future Advisory Votes on Executive Compensation.

SECTION 14A SAY-ON-PAY VOTES

Combines 4 wordings of this item as funds reported it.

99.9% fund support · no official result

8%ONE YEAR 63%1 YEAR 26%

The 287 asset managers below cast 99.9% of the shares they voted on this item FOR (9,761,610 for, 2,646 against).

FOR: 9,761,610 (7.9%)AGAINST: 2,646 (0.0%)ABSTAIN: 0 (0.0%)ONE YEAR: 77,758,404 (63.0%)1 YEAR: 32,279,239 (26.1%)THREE YEARS: 3,581,897 (2.9%)3 YEARS: 89,409 (0.1%)2 YEARS: 15,000 (0.0%)NOT VOTED: 11,546 (0.0%)1-YR: 2,860 (0.0%)1: 2,600 (0.0%)1-YEAR: 1,140 (0.0%)TWO YEARS: 80 (0.0%)3 YEAR: 7 (0.0%)1.0: 0 (0.0%)2 YEAR: 0 (0.0%)3.0: 0 (0.0%)2.0: 0 (0.0%)
Largest asset managers voting on “Recommend, on a non-binding advisory basis, the Frequency of Future Advisory Votes on Executive Compensation.” at NEOGENOMICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock00 001 Year
Vanguard00 00One Year
State Street00 00One Year
T. Rowe Price00 00One Year
First Light Asset Management, LLC5,427,1800 00For
American Century00 00One Year
Janus Henderson00 00One Year
MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST00 00One Year
SCHRODER INVESTMENT MANAGEMENT GROUP00 001 Year
JANUS INVESTMENT FUND00 00One Year
Delaware/Macquarie00 00One Year
Greenhouse Funds LLLP3,620,2250 00For
Dimensional00 00Three Years
BROWN ADVISORY INC00 00One Year
Loomis Sayles00 00One Year
Charles Schwab00 001 Year
GEODE CAPITAL MANAGEMENT, LLC00 00One Year
Fidelity00 00One Year
FRANKLIN ADVISERS INC00 00One Year
JENNISON ASSOCIATES LLC00 001 Year
FRANKLIN STRATEGIC SERIES00 00One Year
SEGALL BRYANT & HAMILL, LLC00 00One Year
Northern Trust00 001 Year
Goldman Sachs00 00One Year
GLENMEDE FUND INC00 00One Year

Showing the 25 largest of 287 asset managers. See all 287 in the interactive database.

3. Approval of the First Amendment of the NeoGenomics, Inc. 2023 Equity Incentive Plan.

COMPENSATION

Combines 2 wordings of this item as funds reported it.

95% fund support · no official result

FOR 95%

The 88 asset managers below cast 95% of the shares they voted on this item FOR (63,565,276 for, 3,112,644 against).

FOR: 63,565,276 (95.2%)AGAINST: 3,112,644 (4.7%)ABSTAIN: 121,100 (0.2%)
Largest asset managers voting on “Approval of the First Amendment of the NeoGenomics, Inc. 2023 Equity Incentive Plan.” at NEOGENOMICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard14,044,1694 00For
BlackRock12,860,1540 00For
First Light Asset Management, LLC5,427,1800 00For
JANUS INVESTMENT FUND4,142,0540 00For
Delaware/Macquarie3,827,2920 00For
Dimensional3,129,5580 00For
American Century02,619,222 00Against
T. Rowe Price2,359,5050 00For
State Street2,001,00978 00For
Fidelity1,578,4400 00For
FRANKLIN STRATEGIC SERIES1,247,1150 00For
Charles Schwab1,037,9070 00For
Loomis Sayles1,019,1080 00For
GLENMEDE FUND INC1,002,1670 00For
Brown Advisory Funds966,3610 00For
Principal788,9810 00For
Goldman Sachs670,2160 00For
Segall Bryant & Hamill Trust508,6180 00For
ALGER FUNDS460,2040 00For
Columbia Threadneedle454,1010 00For
Royce447,4980 00For
AIG/SunAmerica389,0760 00For
Equitable361,5760 9,0000For
FINANCIAL INVESTORS TRUST342,4290 00For
TIAA0329,340 00Against

Showing the 25 largest of 88 asset managers. See all 88 in the interactive database.

4. Election of the directors named in the proxy statement as set forth below: Anthony P. Zook

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

99.4% Majority: yes · of votes cast

FOR 99.4%
FOR: 106,854,626AGAINST: 577,382

NEOGENOMICS INC.’s own tally for this item (“Elect Director: Anthony P. Zook”): 106,854,626 for, 577,382 against, per its Form 8-K filed 2025-05-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 128,356,327 outstanding shares: 83% for, 0.5% against (84% of the company cast a for/against vote).

The 88 asset managers below cast 99.9% of the shares they voted on this item FOR (61,507,173 for, 1 against).

FOR 99.8%
FOR: 61,507,173 (99.8%)AGAINST: 1 (0.0%)ABSTAIN: 0 (0.0%)NOT VOTED: 102,694 (0.2%)
Largest asset managers voting on “Election of the directors named in the proxy statement as set forth below: Anthony P. Zook” at NEOGENOMICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard14,044,1721 00For
BlackRock12,860,1540 00For
JANUS INVESTMENT FUND4,142,0540 00For
Delaware/Macquarie3,827,2920 00For
Dimensional3,129,5580 00For
American Century2,619,2220 00For
T. Rowe Price2,359,5050 00For
State Street2,001,0870 00For
Fidelity1,578,4400 00For
FRANKLIN STRATEGIC SERIES1,247,1150 00For
Charles Schwab1,037,9070 00For
Loomis Sayles1,019,1080 00For
GLENMEDE FUND INC1,002,1670 00For
Brown Advisory Funds966,3610 00For
Principal788,9810 00For
Goldman Sachs670,2160 00For
Segall Bryant & Hamill Trust508,6180 00For
ALGER FUNDS460,2040 00For
Columbia Threadneedle454,1010 00For
Royce447,4980 00For
AIG/SunAmerica389,0760 00For
Equitable370,5760 00For
FINANCIAL INVESTORS TRUST342,4290 00For
TIAA329,3400 00For
Prudential/PGIM300,3480 00For

Showing the 25 largest of 88 asset managers. See all 88 in the interactive database.

5. Election of the directors named in the proxy statement as set forth below: David B. Perez

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%
FOR: 100,863,409AGAINST: 6,606,025

NEOGENOMICS INC.’s own tally for this item (“Elect Director: David B. Perez”): 100,863,409 for, 6,606,025 against, per its Form 8-K filed 2025-05-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 128,356,327 outstanding shares: 79% for, 5% against (84% of the company cast a for/against vote).

The 88 asset managers below cast 93% of the shares they voted on this item FOR (56,942,073 for, 4,565,101 against).

FOR 92%7%
FOR: 56,942,073 (92.4%)AGAINST: 4,565,101 (7.4%)ABSTAIN: 0 (0.0%)NOT VOTED: 102,694 (0.2%)
Largest asset managers voting on “Election of the directors named in the proxy statement as set forth below: David B. Perez” at NEOGENOMICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard14,044,16112 00For
BlackRock12,860,1540 00For
JANUS INVESTMENT FUND4,142,0540 00For
Delaware/Macquarie3,827,2920 00For
Dimensional03,129,558 00Against
American Century2,619,2220 00For
T. Rowe Price2,359,5050 00For
State Street2,001,0870 00For
Fidelity1,578,4400 00For
FRANKLIN STRATEGIC SERIES1,247,1150 00For
Charles Schwab1,037,9070 00For
Loomis Sayles01,019,108 00Against
GLENMEDE FUND INC1,002,1670 00For
Brown Advisory Funds966,3610 00For
Principal788,9810 00For
Goldman Sachs670,2160 00For
Segall Bryant & Hamill Trust508,6180 00For
ALGER FUNDS460,2040 00For
Columbia Threadneedle454,1010 00For
Royce447,4980 00For
AIG/SunAmerica389,0760 00For
Equitable370,5760 00For
FINANCIAL INVESTORS TRUST342,4290 00For
TIAA329,3400 00For
Prudential/PGIM281,34219,006 00For

Showing the 25 largest of 88 asset managers. See all 88 in the interactive database.

6. Election of the directors named in the proxy statement as set forth below: Dr. Alison L. Hannah

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 106,228,894AGAINST: 1,212,694

NEOGENOMICS INC.’s own tally for this item (“Elect Director: Dr. Alison L. Hannah”): 106,228,894 for, 1,212,694 against, per its Form 8-K filed 2025-05-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 128,356,327 outstanding shares: 83% for, 1.0% against (84% of the company cast a for/against vote).

The 88 asset managers below cast 99.9% of the shares they voted on this item FOR (61,507,172 for, 2 against).

FOR 99.8%
FOR: 61,507,172 (99.8%)AGAINST: 2 (0.0%)ABSTAIN: 0 (0.0%)NOT VOTED: 102,694 (0.2%)
Largest asset managers voting on “Election of the directors named in the proxy statement as set forth below: Dr. Alison L. Hannah” at NEOGENOMICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard14,044,1712 00For
BlackRock12,860,1540 00For
JANUS INVESTMENT FUND4,142,0540 00For
Delaware/Macquarie3,827,2920 00For
Dimensional3,129,5580 00For
American Century2,619,2220 00For
T. Rowe Price2,359,5050 00For
State Street2,001,0870 00For
Fidelity1,578,4400 00For
FRANKLIN STRATEGIC SERIES1,247,1150 00For
Charles Schwab1,037,9070 00For
Loomis Sayles1,019,1080 00For
GLENMEDE FUND INC1,002,1670 00For
Brown Advisory Funds966,3610 00For
Principal788,9810 00For
Goldman Sachs670,2160 00For
Segall Bryant & Hamill Trust508,6180 00For
ALGER FUNDS460,2040 00For
Columbia Threadneedle454,1010 00For
Royce447,4980 00For
AIG/SunAmerica389,0760 00For
Equitable370,5760 00For
FINANCIAL INVESTORS TRUST342,4290 00For
TIAA329,3400 00For
Prudential/PGIM300,3480 00For

Showing the 25 largest of 88 asset managers. See all 88 in the interactive database.

7. Election of the directors named in the proxy statement as set forth below: Dr. Neil Gunn

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%
FOR: 100,989,260AGAINST: 6,479,243

NEOGENOMICS INC.’s own tally for this item (“Elect Director: Dr. Neil Gunn”): 100,989,260 for, 6,479,243 against, per its Form 8-K filed 2025-05-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 128,356,327 outstanding shares: 79% for, 5% against (84% of the company cast a for/against vote).

The 88 asset managers below cast 93% of the shares they voted on this item FOR (56,938,168 for, 4,569,006 against).

FOR 92%7%
FOR: 56,938,168 (92.4%)AGAINST: 4,569,006 (7.4%)ABSTAIN: 0 (0.0%)NOT VOTED: 102,694 (0.2%)
Largest asset managers voting on “Election of the directors named in the proxy statement as set forth below: Dr. Neil Gunn” at NEOGENOMICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard14,044,16112 00For
BlackRock12,860,1540 00For
JANUS INVESTMENT FUND4,142,0540 00For
Delaware/Macquarie3,827,2920 00For
Dimensional03,129,558 00Against
American Century2,619,2220 00For
T. Rowe Price2,359,5050 00For
State Street2,001,0870 00For
Fidelity1,578,4400 00For
FRANKLIN STRATEGIC SERIES1,247,1150 00For
Charles Schwab1,037,9070 00For
Loomis Sayles01,019,108 00Against
GLENMEDE FUND INC1,002,1670 00For
Brown Advisory Funds966,3610 00For
Principal788,9810 00For
Goldman Sachs670,2160 00For
Segall Bryant & Hamill Trust508,6180 00For
ALGER FUNDS460,2040 00For
Columbia Threadneedle454,1010 00For
Royce447,4980 00For
AIG/SunAmerica389,0760 00For
Equitable370,5760 00For
FINANCIAL INVESTORS TRUST342,4290 00For
TIAA329,3400 00For
Prudential/PGIM281,34219,006 00For

Showing the 25 largest of 88 asset managers. See all 88 in the interactive database.

8. Election of the directors named in the proxy statement as set forth below: Elizabeth A. Floegel

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

99.1% Majority: yes · of votes cast

FOR 99.1%
FOR: 106,521,107AGAINST: 909,207

NEOGENOMICS INC.’s own tally for this item (“Elect Director: Elizabeth A. Floegel”): 106,521,107 for, 909,207 against, per its Form 8-K filed 2025-05-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 128,356,327 outstanding shares: 83% for, 0.8% against (84% of the company cast a for/against vote).

The 88 asset managers below cast 99.9% of the shares they voted on this item FOR (61,507,172 for, 1 against).

FOR 99.8%
FOR: 61,507,172 (99.8%)AGAINST: 1 (0.0%)ABSTAIN: 0 (0.0%)NOT VOTED: 102,694 (0.2%)
Largest asset managers voting on “Election of the directors named in the proxy statement as set forth below: Elizabeth A. Floegel” at NEOGENOMICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard14,044,1711 00For
BlackRock12,860,1540 00For
JANUS INVESTMENT FUND4,142,0540 00For
Delaware/Macquarie3,827,2920 00For
Dimensional3,129,5580 00For
American Century2,619,2220 00For
T. Rowe Price2,359,5050 00For
State Street2,001,0870 00For
Fidelity1,578,4400 00For
FRANKLIN STRATEGIC SERIES1,247,1150 00For
Charles Schwab1,037,9070 00For
Loomis Sayles1,019,1080 00For
GLENMEDE FUND INC1,002,1670 00For
Brown Advisory Funds966,3610 00For
Principal788,9810 00For
Goldman Sachs670,2160 00For
Segall Bryant & Hamill Trust508,6180 00For
ALGER FUNDS460,2040 00For
Columbia Threadneedle454,1010 00For
Royce447,4980 00For
AIG/SunAmerica389,0760 00For
Equitable370,5760 00For
FINANCIAL INVESTORS TRUST342,4290 00For
TIAA329,3400 00For
Prudential/PGIM300,3480 00For

Showing the 25 largest of 88 asset managers. See all 88 in the interactive database.

9. Election of the directors named in the proxy statement as set forth below: Felicia Williams

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

99.2% Majority: yes · of votes cast

FOR 99.2%
FOR: 106,671,209AGAINST: 779,504

NEOGENOMICS INC.’s own tally for this item (“Elect Director: Felicia Williams”): 106,671,209 for, 779,504 against, per its Form 8-K filed 2025-05-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 128,356,327 outstanding shares: 83% for, 0.7% against (84% of the company cast a for/against vote).

The 88 asset managers below cast 99.9% of the shares they voted on this item FOR (61,507,173 for, 1 against).

FOR 99.8%
FOR: 61,507,173 (99.8%)AGAINST: 1 (0.0%)ABSTAIN: 0 (0.0%)NOT VOTED: 102,694 (0.2%)
Largest asset managers voting on “Election of the directors named in the proxy statement as set forth below: Felicia Williams” at NEOGENOMICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard14,044,1721 00For
BlackRock12,860,1540 00For
JANUS INVESTMENT FUND4,142,0540 00For
Delaware/Macquarie3,827,2920 00For
Dimensional3,129,5580 00For
American Century2,619,2220 00For
T. Rowe Price2,359,5050 00For
State Street2,001,0870 00For
Fidelity1,578,4400 00For
FRANKLIN STRATEGIC SERIES1,247,1150 00For
Charles Schwab1,037,9070 00For
Loomis Sayles1,019,1080 00For
GLENMEDE FUND INC1,002,1670 00For
Brown Advisory Funds966,3610 00For
Principal788,9810 00For
Goldman Sachs670,2160 00For
Segall Bryant & Hamill Trust508,6180 00For
ALGER FUNDS460,2040 00For
Columbia Threadneedle454,1010 00For
Royce447,4980 00For
AIG/SunAmerica389,0760 00For
Equitable370,5760 00For
FINANCIAL INVESTORS TRUST342,4290 00For
TIAA329,3400 00For
Prudential/PGIM300,3480 00For

Showing the 25 largest of 88 asset managers. See all 88 in the interactive database.

10. Election of the directors named in the proxy statement as set forth below: Lynn A. Tetrault

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%
FOR: 100,642,889AGAINST: 6,808,246

NEOGENOMICS INC.’s own tally for this item (“Elect Director: Lynn A. Tetrault”): 100,642,889 for, 6,808,246 against, per its Form 8-K filed 2025-05-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 128,356,327 outstanding shares: 78% for, 5% against (84% of the company cast a for/against vote).

The 88 asset managers below cast 93% of the shares they voted on this item FOR (56,936,783 for, 4,570,391 against).

FOR 92%7%
FOR: 56,936,783 (92.4%)AGAINST: 4,570,391 (7.4%)ABSTAIN: 0 (0.0%)NOT VOTED: 102,694 (0.2%)
Largest asset managers voting on “Election of the directors named in the proxy statement as set forth below: Lynn A. Tetrault” at NEOGENOMICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard14,039,7234,450 00For
BlackRock12,860,1540 00For
JANUS INVESTMENT FUND4,142,0540 00For
Delaware/Macquarie3,827,2920 00For
Dimensional03,129,558 00Against
American Century2,619,2220 00For
T. Rowe Price2,359,5050 00For
State Street2,001,0870 00For
Fidelity1,578,4400 00For
FRANKLIN STRATEGIC SERIES1,247,1150 00For
Charles Schwab1,037,9070 00For
Loomis Sayles01,019,108 00Against
GLENMEDE FUND INC1,002,1670 00For
Brown Advisory Funds966,3610 00For
Principal788,9810 00For
Goldman Sachs670,2160 00For
Segall Bryant & Hamill Trust508,6180 00For
ALGER FUNDS460,2040 00For
Columbia Threadneedle454,1010 00For
Royce447,4980 00For
AIG/SunAmerica389,0760 00For
Equitable370,5760 00For
FINANCIAL INVESTORS TRUST342,4290 00For
TIAA329,3400 00For
Prudential/PGIM281,34219,006 00For

Showing the 25 largest of 88 asset managers. See all 88 in the interactive database.

11. Election of the directors named in the proxy statement as set forth below: Michael A. Kelly

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%
FOR: 100,543,917AGAINST: 6,924,001

NEOGENOMICS INC.’s own tally for this item (“Elect Director: Michael A. Kelly”): 100,543,917 for, 6,924,001 against, per its Form 8-K filed 2025-05-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 128,356,327 outstanding shares: 78% for, 5% against (84% of the company cast a for/against vote).

The 88 asset managers below cast 93% of the shares they voted on this item FOR (56,938,168 for, 4,569,006 against).

FOR 92%7%
FOR: 56,938,168 (92.4%)AGAINST: 4,569,006 (7.4%)ABSTAIN: 0 (0.0%)NOT VOTED: 102,694 (0.2%)
Largest asset managers voting on “Election of the directors named in the proxy statement as set forth below: Michael A. Kelly” at NEOGENOMICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard14,044,16112 00For
BlackRock12,860,1540 00For
JANUS INVESTMENT FUND4,142,0540 00For
Delaware/Macquarie3,827,2920 00For
Dimensional03,129,558 00Against
American Century2,619,2220 00For
T. Rowe Price2,359,5050 00For
State Street2,001,0870 00For
Fidelity1,578,4400 00For
FRANKLIN STRATEGIC SERIES1,247,1150 00For
Charles Schwab1,037,9070 00For
Loomis Sayles01,019,108 00Against
GLENMEDE FUND INC1,002,1670 00For
Brown Advisory Funds966,3610 00For
Principal788,9810 00For
Goldman Sachs670,2160 00For
Segall Bryant & Hamill Trust508,6180 00For
ALGER FUNDS460,2040 00For
Columbia Threadneedle454,1010 00For
Royce447,4980 00For
AIG/SunAmerica389,0760 00For
Equitable370,5760 00For
FINANCIAL INVESTORS TRUST342,4290 00For
TIAA329,3400 00For
Prudential/PGIM281,34219,006 00For

Showing the 25 largest of 88 asset managers. See all 88 in the interactive database.

12. Election of the directors named in the proxy statement as set forth below: Stephen M. Kanovsky

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 106,382,228AGAINST: 1,084,969

NEOGENOMICS INC.’s own tally for this item (“Elect Director: Stephen M. Kanovsky”): 106,382,228 for, 1,084,969 against, per its Form 8-K filed 2025-05-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 128,356,327 outstanding shares: 83% for, 0.9% against (84% of the company cast a for/against vote).

The 88 asset managers below cast 99.9% of the shares they voted on this item FOR (61,507,172 for, 2 against).

FOR 99.8%
FOR: 61,507,172 (99.8%)AGAINST: 2 (0.0%)ABSTAIN: 0 (0.0%)NOT VOTED: 102,694 (0.2%)
Largest asset managers voting on “Election of the directors named in the proxy statement as set forth below: Stephen M. Kanovsky” at NEOGENOMICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard14,044,1712 00For
BlackRock12,860,1540 00For
JANUS INVESTMENT FUND4,142,0540 00For
Delaware/Macquarie3,827,2920 00For
Dimensional3,129,5580 00For
American Century2,619,2220 00For
T. Rowe Price2,359,5050 00For
State Street2,001,0870 00For
Fidelity1,578,4400 00For
FRANKLIN STRATEGIC SERIES1,247,1150 00For
Charles Schwab1,037,9070 00For
Loomis Sayles1,019,1080 00For
GLENMEDE FUND INC1,002,1670 00For
Brown Advisory Funds966,3610 00For
Principal788,9810 00For
Goldman Sachs670,2160 00For
Segall Bryant & Hamill Trust508,6180 00For
ALGER FUNDS460,2040 00For
Columbia Threadneedle454,1010 00For
Royce447,4980 00For
AIG/SunAmerica389,0760 00For
Equitable370,5760 00For
FINANCIAL INVESTORS TRUST342,4290 00For
TIAA329,3400 00For
Prudential/PGIM300,3480 00For

Showing the 25 largest of 88 asset managers. See all 88 in the interactive database.

13. RATIFICATION OF THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM.

AUDIT-RELATEDMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

99.8% Majority: yes · of votes cast

FOR 99.8%
FOR: 112,929,861AGAINST: 157,649

NEOGENOMICS INC.’s own tally for this item (“Proposal 5: The ratification of the appointment of Deloitte & Touche LLP as the independent registered public accountant. The stockholders approved the proposal by the following vote:”): 112,929,861 for, 157,649 against, per its Form 8-K filed 2025-05-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 128,356,327 outstanding shares: 88% for, 0.2% against (88% of the company cast a for/against vote).

The 88 asset managers below cast 99.9% of the shares they voted on this item FOR (61,451,441 for, 55,733 against).

FOR 99.7%
FOR: 61,451,441 (99.7%)AGAINST: 55,733 (0.1%)ABSTAIN: 0 (0.0%)NOT VOTED: 102,694 (0.2%)
Largest asset managers voting on “RATIFICATION OF THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUN” at NEOGENOMICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard14,044,1730 00For
BlackRock12,860,1540 00For
JANUS INVESTMENT FUND4,142,0540 00For
Delaware/Macquarie3,827,2920 00For
Dimensional3,129,5580 00For
American Century2,619,2220 00For
T. Rowe Price2,359,5050 00For
State Street2,001,0870 00For
Fidelity1,578,4400 00For
FRANKLIN STRATEGIC SERIES1,247,1150 00For
Charles Schwab1,037,9070 00For
Loomis Sayles1,019,1080 00For
GLENMEDE FUND INC1,002,1670 00For
Brown Advisory Funds966,3610 00For
Principal788,9810 00For
Goldman Sachs670,2160 00For
Segall Bryant & Hamill Trust508,6180 00For
ALGER FUNDS460,2040 00For
Columbia Threadneedle454,1010 00For
Royce447,4980 00For
AIG/SunAmerica389,0760 00For
Equitable370,5760 00For
FINANCIAL INVESTORS TRUST342,4290 00For
TIAA329,3400 00For
Prudential/PGIM300,3480 00For

Showing the 25 largest of 88 asset managers. See all 88 in the interactive database.

14. Advisory Vote on Say on Pay Frequency

SECTION 14A SAY-ON-PAY VOTES

100% fund support · no official result

FOR 19%ONE YEAR 64%NOT VOTED 17%

The 10 asset managers below cast 100% of the shares they voted on this item FOR (110,355 for, 0 against).

FOR: 110,355 (18.6%)ONE YEAR: 378,230 (63.6%)NOT VOTED: 102,694 (17.3%)1 YEAR: 3,478 (0.6%)
Largest asset managers voting on “Advisory Vote on Say on Pay Frequency” at NEOGENOMICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
JPMorgan00 00One Year
GuideStone00 00One Year
Empower00 00Not Voted
NORDEA INVESTMENT MANAGEMENT AB81,9600 00For
LITMAN GREGORY FUNDS TRUST28,3950 00For
CLEARWATER INVESTMENT TRUST00 00One Year
Desjardins Global Asset Management Inc.00 00One Year
Coyle Financial Counsel LLC00 001 Year
SIERRA SUMMIT ADVISORS LLC00 001 Year
Uniplan Investment Counsel, Inc.00 001 Year

15. Amend Omnibus Stock Plan

COMPENSATION

97% fund support · no official result

FOR 60%NOT VOTED 38%

The 4 asset managers below cast 97% of the shares they voted on this item FOR (164,460 for, 4,980 against).

FOR: 164,460 (60.4%)AGAINST: 4,980 (1.8%)NOT VOTED: 102,694 (37.7%)
Largest asset managers voting on “Amend Omnibus Stock Plan” at NEOGENOMICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
GuideStone136,0650 00For
Empower00 00Not Voted
LITMAN GREGORY FUNDS TRUST28,3950 00For
CLEARWATER INVESTMENT TRUST04,980 00Against

Largest NEOGENOMICS INC. shareholders voting in 2024-2025

Ranked by the number of NEOGENOMICS INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 128,356,327 shares outstanding at the time of that meeting.

Top NEOGENOMICS INC. shareholders by shares voted, 2024-2025
#Asset manager % of shares outstanding
1BlackRock 12.88%
2Vanguard 11.22%
3State Street 5.15%
4T. Rowe Price 4.61%
5First Light Asset Management, LLC 4.23%
6American Century 4.19%
7Janus Henderson 3.99%
8MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST 3.30%
9SCHRODER INVESTMENT MANAGEMENT GROUP 3.26%
10JANUS INVESTMENT FUND 3.23%

Reported NEOGENOMICS INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

NEOGENOMICS INC. beneficial owners on record for the 2024-2025 proxy season
Holder % outstanding Disclosure
BlackRock 15.48% 13F
Vanguard Group 11.11% 13F
First Light Asset Management, LLC 10.62% 13G
Brown Advisory Incorporated 7.43% DEF14A
Greenhouse Funds LLLP 7.18% 13G
Vanguard Portfolio Management 5.98% 13G
Millennium Management 5.45% 13F
Integrated Core Strategies (US) LLC 5.42% 13G
JANUS HENDERSON GROUP PLC 4.80% 13G
State Street 3.97% 13F

Percentages above are of 128,356,327 shares outstanding, as reported by NEOGENOMICS INC. on its Form 10-Q dated 2025-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from NEOGENOMICS INC.’s 10-Q dated 2025-03-31. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.

At NEOGENOMICS INC.'s shareholder meeting held 2025-05-22, in the 2024-2025 proxy season, 306 asset managers reported how they voted in their SEC Form N-PX filings, covering 4,283 separate fund positions. Their filings are grouped here into 15 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Approval, on a non-binding advisory basis, of the Compensation Paid to the Company's Named… — FOR was 82% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: NEOGENOMICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-05-27.

NEOGENOMICS INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.